Park Ha Biological Technology is trading 6.02% higher at $3.34, outperforming after a highly volatile recent session as cooler inflation supported broader risk appetite.

  • The S&P 500 is up 0.55% and the Nasdaq Composite is up 0.80%.
  • A securities-class-action deadline reminder published August 13, 2026, offers no clear company-specific explanation for the intraday gain.
  • The lawsuit’s September 28 lead-plaintiff deadline remains an overhang.